Multi-Peptide Blends

The multi-peptide-blends shelf collects pre-combined preparations at fixed mass ratios drawn from the published preclinical literature. The premise: when a research protocol uses two or more compounds at documented ratios, pre-blending them into a single vial means one reconstitution gives both peptides at the cited dose ratio — fewer pipetting steps, lower risk of ratio drift across the protocol.

The BPC+TB blend is the canonical combined-mechanism preparation in soft-tissue repair research. BPC-157 and TB-500 individually carry deep preclinical literatures (gastric and tendon for BPC-157; thymosin β-4-derived actin-binding for TB-500); the combined-administration protocols originate primarily from the Sikiric and Maquart groups. The GLOW blend layers in GHK-Cu for the copper-coordination chemistry studied in dermal and wound contexts. The KLOW blend extends GLOW with KPV for an additional mucosal-inflammation arm.

A practical note on blends: the individual-component literature does not transfer directly to the combined preparation — synergy, antagonism, and dose-response curves may differ. No combined-blend protocol in this shelf is documented in peer-reviewed phase 1+ human research; the rationale is component-level data and replication convenience. Each vial includes a documented mass per peptide so researchers can compute the effective dose of each constituent during reconstitution. For research use only; not for human or veterinary consumption.